Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Lancaster. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Lancaster at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or per stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this crohn's disease clinical trial in Lancaster, CA
If you're searching for crohn's disease treatment options in Lancaster, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lancaster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.